LENZ Therapeutics Reports Strong Initial VIZZ Launch with $1.6M Revenue and High ECP Adoption in Q4 2025

summarizeSummary

LENZ Therapeutics announced preliminary Q4 2025 results, reporting $1.6 million in VIZZ net product revenue and strong early market adoption with over 20,000 prescriptions and high repeat ECP prescribing rates, exceeding expectations.

check_boxKey Events

• Strong Initial VIZZ Launch Performance

  LENZ Therapeutics reported over 20,000 VIZZ prescriptions filled in Q4 2025, with more than 6,500 unique Eye Care Professionals (ECPs) prescribing the product, and over 55% of those ECPs prescribing multiple times, indicating robust early market acceptance.

• Preliminary Q4 2025 Net Product Revenue

  The company achieved approximately $1.6 million in net product revenue for VIZZ during its first commercial quarter ended December 31, 2025, exceeding internal expectations.

• New International Commercialization Partnership

  LENZ announced an exclusive commercialization partnership with Lunatus for VIZZ in the Middle East, marking the fourth international agreement and including upfront, regulatory, and commercial milestone payments, plus a significant revenue share.

• Upcoming Direct-to-Consumer Campaign

  A Direct-to-Consumer (DTC) campaign for VIZZ, featuring spokesperson Sarah Jessica Parker, is scheduled to launch in the current quarter, aiming to further boost product awareness and demand.

auto_awesomeAnalysis

LENZ Therapeutics has reported highly encouraging preliminary results for the first commercial quarter of its presbyopia treatment, VIZZ. The $1.6 million in net product revenue, while modest in absolute terms, is significant as it represents the initial market penetration for the company's sole commercial product. The rapid uptake, evidenced by over 20,000 prescriptions and more than 6,500 unique Eye Care Professionals (ECPs) prescribing VIZZ (with over 55% prescribing multiple times), indicates strong early market acceptance and physician confidence. This strong adoption rate, coupled with the announcement of a fourth international commercialization partnership for VIZZ in the Middle East, suggests a positive trajectory for global expansion and future revenue growth. The upcoming Direct-to-Consumer campaign with Sarah Jessica Parker is expected to further accelerate market awareness and demand.